We rarely know where our medicines originate. The global pharmaceutical supply chain is an opaque network of chemical synthesis facilities, […]
Pharm to Table: Map Supply Chains and Predict Drug Shortages Using Patent Data Read Post »
TAVALISSE (fostamatinib disodium) Rigel pharms Patent: 7,538,108 Expiration: Mar 28, 2026 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of March 22, 2026 Read Post »
1. Why Patent Expiry Forecasting Is a Revenue-Critical Discipline ‘Between 2025 and 2030, approximately 190 drugs will lose market exclusivity,
1. The $2.8 Trillion Arithmetic: Market Structure and Strategic Stakes The global pharmaceutical market reached approximately $1.6 trillion in 2024
A deep dive covering the ANDA pathway, EU MAA procedures, bioequivalence science, Paragraph IV litigation strategy, patent cliff analysis, evergreening
The $236 Billion Race Most Procurement Teams Are Losing Between 2025 and 2030, more than $236 billion in branded pharmaceutical
I. Market Context: Why the CDMO Sector Is Repricing The global pharmaceutical CDMO market hit approximately $181.93 billion in 2025,
1. The Cliff Everyone Sees Coming — and Still Falls Off Every branded pharmaceutical product carries a date of death.
An investigative analysis of patent thickets, design-around strategies, and competitive intelligence for pharmaceutical generics manufacturers The Wall Every Generic Manufacturer
Sign in or create a free account to read this DrugPatentWatch article
